Notes - Segment Information, Etc.

ASKA Pharmaceutical Holdings CO., Ltd. - Filing #7328356

Concept 2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
Notes - Segment information, etc.
Segment information
Disclosure of sales and profit (loss) for each reportable segment
Sales
Revenues from external customers
56,016,000,000 JPY
62,843,000,000 JPY
JPY
162,000,000 JPY
62,843,000,000 JPY
6,664,000,000 JPY
6,660,000,000 JPY
53,579,000,000 JPY
60,461,000,000 JPY
220,000,000 JPY
JPY
60,461,000,000 JPY
Transactions with other segments
JPY
JPY
-64,000,000 JPY
64,000,000 JPY
64,000,000 JPY
JPY
JPY
JPY
77,000,000 JPY
77,000,000 JPY
-77,000,000 JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.